StonvexLoading…
StonvexStonvexStonvexCore line items from ENSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.47B | $1.38B | $5.03B | $3.68B | $2.39B |
Operating Income | Not available | $124.85M | $425.31M | $301.49M | $205.28M |
Net Income | Not available | $99.67M | $343.97M | $248.52M | $84.40M |
EPS (Diluted) | $1.88 | $1.67 | $5.84 | $4.23 | $2.81 |
Total Assets | Not available | $5.61B | $5.46B | $5.23B | $4.93B |
Total Liabilities | Not available | $3.24B | $3.23B | $3.10B | $2.91B |
Cash & Equivalents | Not available | $539.50M | $503.88M | $443.67M | $363.97M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 58.42M | 58.09M | 57.90M | 57.68M |